Search COVID-19 Rapid Resource Center or explore resources sorted by Category or Content Type.


NIH Resource: The COVID-19 Treatment Guidelines Panel’s Interim Statement on Patient Prioritization for Outpatient Anti-SARS-CoV-2 Therapies or Preventive Strategies When There Are Logistical or Supply Constraints

The COVID-19 Treatment Guidelines Panel (the Panel) has recommended several therapeutic agents for the treatment and prevention of SARS-CoV-2 infection in individuals who are at high risk for progression to severe COVID-19. These anti-SARS-CoV-2 therapeutics are of greatest be...

WHO Resource: WHO Therapeutics and COVID-19: living guideline

The WHO Therapeutics and COVID-19: living guideline contains the Organization’s most up-to-date recommendations for the use of therapeutics in the treatment of COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via ...

   Estimated Time: Coronavirus, COVID-19, Therapies

AHA Resource: How a Bold, New Strategy Took on Health Care Inequities During the Pandemic (Blog)

AHA published a new blog post from an LLN member hospital titled,  The Pandemic. “How a Bold, New Strategy Took on Health Care Inequities During the Pandemic,” authored by Luminis Health Chief Diversity Officer Tamiko Stanley.  

FDA Resource: Paxlovid received EUA approval from the FDA

December 22, 2021, the FDA issued an emergency use authorization (EUA) for Pfizer’s Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) for the treatment of mild-to-moderate coronavirus disease (COVID-19) in adults and pediatric patients (12 years o...

   Estimated Time: Coronavirus, COVID-19, Therapies

FDA Resource: Molnupiravir received EUA approval from the FDA

The FDA has granted molnupiravir emergency use authorization (EUA) to treat mild to moderate COVID-19 in adults at high risk of severe illness. High risk people include adults aged 65 and over and people with certain medical conditions. The FDA also states that molnupiravir sh...

   Estimated Time: Coronavirus, COVID-19, Therapies

ATS Resource: Critical Perspective: Bacterial Superinfection in Patients Mechanically Ventilated for COVID-19 Pneumonia (Podcast)

In this “Breathe Easy Critical Perspective” podcast, Dr. Dominique Pepper interviews Dr. Richard Wunderink They discuss Dr. Wunderink's recent publication in the Blue Journal about bacterial superinfection in patients intubated and mechanically ventilated for COVID-19 pneumoni...

AHA Resource: Nurse leaders discuss COVID-19 nursing challenges, solutions (Podcast)

The fourth and current wave of the COVID-19 pandemic has created a worrisome landscape for the nursing profession. Nurses across the country report that they no longer feel celebrated as heroes as they did in the early days of the pandemic. This AHA Podcast covers nurse leader...

   Estimated Time: Coronavirus, COVID-19, Mental Health

HHS Resource: Surgeon General Releases Community Toolkit for Addressing Health Misinformation

During the COVID-19 pandemic, people have been exposed to an abundance of information from a large number of sources.

   Estimated Time: Communication, Coronavirus, COVID-19

FDA News Release: FDA Expands Authorization of Two Monoclonal Antibodies for Treatment and Post-Exposure Prevention of COVID-19 to Younger Pediatric Patients, Including Newborns

On December 3, 2021, the U.S. Food and Drug Administration revised the emergency use authorization (EUA) of bamlanivimab and etesevimab (previously authorized for pediatric patients 12 years of age and older weighing at least 40 kilograms, or about 88 pounds), to additionally ...

   Estimated Time: Coronavirus, COVID-19, pediatrics

Family Presence Policy Decision-Making Toolkit for Nurse Leaders

Questions to Guide Evidence-Informed, Data Driven and Person-Centered Decision-Making. Summary of evidence and sources

   Estimated Time: Communication, Coronavirus, COVID-19

CHEST Resource: Pulmonary Thrombosis and Thromboembolism in COVID-19

In this review, the epidemiologic and pathophysiologic features, diagnosis, and treatment of COVID-19 pulmonary thrombosis and thromboembolism are discussed.

   Estimated Time: Coronavirus, COVID-19

CHEST Resource: Post intensive Care Syndrome (PICS)

Infographic: Symptoms, Risk Factors, Screening, Recovery Programs

   Estimated Time: Coronavirus, COVID-19, PICS

CHEST Resource: COVID-19 and Risk of VTE in Ethnically Diverse Populations

Research Question: Does the rate of VTE among adults hospitalized with COVID-19 differ from matched hospitalized control participants without COVID-19?

   Estimated Time: Coronavirus, COVID-19

CHEST Resource: Cardiopulmonary Resuscitation in the COVID-19 Era

COVID in Focus: Perspectives on the Literature. Brief summary and highlights specific studies in the COVID-19 literature is a curated review of key information and literature about this topic. It is not comprehensive of all data related to this subject.

   Estimated Time: Coronavirus, COVID-19, Ventilatory Support